Apoptosis and tumor inhibition induced by human chorionic gonadotropin beta in mouse breast carcinoma

Journal of Molecular Medicine

Volumn 84, Issue 11, 2006, Pages 933-941

  Shi, Shu Qun ^a,b   Xu, Li ^a,b   Zhao, Gang ^a,b   Yang, Ying ^a   Peng, Jing Pian ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Breast cancer; hCG ; Tumor model; Tumor repression

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; GELATINASE B; PROTEIN BAX; PROTEIN P21; VASCULOTROPIN;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOCRINE FUNCTION; GROWTH INHIBITION; HORMONE RELEASE; MAMMARY GLAND; MOUSE; NONHUMAN; PREGNANCY; PROTEIN EXPRESSION; TROPHOBLAST; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750454826     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0085-x     Document Type: Article

References (32)

1. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2(9):533-543
2. Gao RJ, Bao HZ, Yang Q, Cong Q, Song JN, Wang L (2005) The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters. Breast Cancer Res Treat 93(2):111-115
3. Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon S (2001) Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res 61(24):8845-8850
4. Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR,Beex LV, Sweep CG (2003) Molecular beacon reverse transcription-PCR of human chorionic gonadotropin-beta-3, -5, and -8 mRNAs has prognostic value in breast cancer. Clin Chem 49 (7):1074-1080
5. Srivastava P, Russo J, Russo IH (1997) Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis 18(9):1799-1808
6. Rao ChV, Li X, Manna SK, Lei ZM, Aggarwal BB (2004) Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation. J Biol Chem 279(24):22510-25503
7. Pulaski BA, Ostrand-Rosenberg S (1998) Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res 58(7):1486-1493
8. Banka CL, Lund CV, Nguyen MT, Pakchoian AJ, Mueller BM, Eliceiri BP (2006) Estrogen induces lung metastasis through a host compartment-specific response. Cancer Res 66(7):3667-3672
9. Medina D (2004) Breast cancer: the protective effect of pregnancy. Clin Cancer Res 10(1 pt 2):380-384 (Suppl)
10. Grubbs CJ, Juliana MM, Whitaker LM (1988) Short-term hormone treatment as a chemopreventive method against mammary cancer initiation in rats. Anticancer Res 8(1):113-117
11. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S (1999) Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 962:2520-2525
12. Russo IH, Koszalka M, Russo J (1991) Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer 64(3):481-484
13. Medina D, Kittrell FS (2003) p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res 63(19):6140-6143
14. Sivaraman L, Conneely OM, Medina D, O'Malley BW (2001) p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci USA 98(22):12379-12384
15. Pati D, Haddad BR, Haegele A, Thompson H, Kittrell FS, Shepard A, Montagna C, Zhang N, Ge G, Otta SK, McCarthy M, Ullrich RL, Medina D (2004) Hormone-induced chromosomal instability in p53-null mammary epithelium. Cancer Res 64(16):5608-5616
16. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88(3):323-331
17. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators ofG1-phase progression. Genes Dev 13(2):1501-1512
18. Modestou M, Puig-Antich V, Korgaonkar C, Eapen A, Quelle DE (2001) The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways. Cancer Res 61(7):3145-3150
19. Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL (2001) Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations duringmyc-mediated lymphomagenesis. Mol Cell Biol 21(22):7653-7662
20. Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G (2002) Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512(1-3):334-340
21. Zhang L, Yang N, Carcia JR, Mohamed A, Benencia F, Rubin SC, Allman D, Coukos G (2002) Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. Am J Pathol 161(16):2295-2309
22. Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S (2004) Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res 64(6):2205-2211
23. Siler-Khodr TM, Yu FQ, Wei P, Tao SX, Liu YQ (2004) Contraceptive action of a gonadotropin-releasing hormone II analog in the rhesus monkey. J Clin Endocrinol Metab 89(9):4513-4520
24. Guo S, Russo IH, Lareef MH, Russo J (2004) Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int J Oncol 24(2):399-407
25. Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF (2002) CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 22(24):8709-8720
26. Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Wey JS, Parikh AA, Fan F, Reinmuth N, Kawaguchi M, Bucana CD, Ellis LM (2003) Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res 63(12):3370-3377
27. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP (2004) Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279(49):51630-51646
28. Gasco M, Shami S, Crook T (2002) The p53 pathway in breast cancer. Cancer Res 4(2):70-76
29. Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, Bonilla PJ, Butel JS, Medina D (2000) A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene 19(8):1052-1058
30. Ling XY, Arlinghaus RB (2005) Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res 65(7):2532-2536
31. Stewart ZA, Leach SD, Pietenpol JA (1999) p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol Cell Biol 19(1):205-215
32. Pal S, Datta K, Mukhopadhyay D (2001) Central role of p53 on regulation of vascular permeability vascular endothelial growth factor (VPF/VEGF) in mammary carcinoma. Cancer Res 61(18):6952-6957